2BB score and signals
Cognition Therapeutics, Inc.’s current 2BB score is 18 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 10 | Very Weak |
| Quality | 40 | Normal |
| Risk | 45 | Moderate |
Company facts
| Founded | Jan 1, 2007 |
| Employees | 14 |
| 52-week range | $0.55 – $3.83 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | -0.068 | — | $0.00 |
| 2026-08-11 | — | -0.0638 | — | $0.00 |
| 2026-05-08 | -0.05 | -0.0689 | $0.00 | $0.00 |
| 2026-03-26 | -0.048 | -0.085 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish